# Tramadol/Diclofenac Fixed-dose Combination Phase III Trial in Acute Pain After Third Molar Extraction

> **NCT03714672** · PHASE3 · COMPLETED · sponsor: **Grünenthal GmbH** · enrollment: 1151 (actual)

## Conditions studied

- Acute Pain

## Interventions

- **DRUG:** Tramadol/Diclofenac 50/50
- **DRUG:** Tramadol/Diclofenac 25/25
- **DRUG:** Tramadol 50
- **DRUG:** Diclofenac 50

## Key facts

- **NCT ID:** NCT03714672
- **Lead sponsor:** Grünenthal GmbH
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-08-26
- **Primary completion:** 2018-03-09
- **Final completion:** 2018-03-22
- **Target enrollment:** 1151 (ACTUAL)
- **Last updated:** 2019-07-24

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03714672

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03714672, "Tramadol/Diclofenac Fixed-dose Combination Phase III Trial in Acute Pain After Third Molar Extraction". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT03714672. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*